Growing community of inventors

Cambridge, MA, United States of America

Gregory V Kryukov

Average Co-Inventor Count = 5.43

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 26

Gregory V KryukovMichael R Schlabach (11 patents)Gregory V KryukovJason J Merkin (11 patents)Gregory V KryukovMicah Benson (9 patents)Gregory V KryukovSolomon Martin Shenker (9 patents)Gregory V KryukovNoah Jacob Tubo (9 patents)Gregory V KryukovJames Martin Kaberna, Ii (6 patents)Gregory V KryukovGregory V Kryukov (11 patents)Michael R SchlabachMichael R Schlabach (14 patents)Jason J MerkinJason J Merkin (11 patents)Micah BensonMicah Benson (12 patents)Solomon Martin ShenkerSolomon Martin Shenker (9 patents)Noah Jacob TuboNoah Jacob Tubo (9 patents)James Martin Kaberna, IiJames Martin Kaberna, Ii (6 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Ksq Therapeutics, Inc. (11 from 17 patents)


11 patents:

1. 12280111 - Gene-regulating compositions and methods for improved immunotherapy

2. 12123021 - Gene-regulating compositions and methods for improved immunotherapy

3. 12084682 - Gene-regulating compositions and methods for improved immunotherapy

4. 11946163 - Methods for measuring and improving CRISPR reagent function

5. 11608500 - Gene-regulating compositions and methods for improved immunotherapy

6. 11459544 - Gene-regulating compositions and methods for improved immunotherapy

7. 11421228 - Gene-regulating compositions and methods for improved immunotherapy

8. 11332713 - Gene-regulating compositions and methods for improved immunotherapy

9. 11261428 - Gene-regulating compositions and methods for improved immunotherapy

10. 11111493 - Gene-regulating compositions and methods for improved immunotherapy

11. 11078483 - Methods for measuring and improving CRISPR reagent function

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/6/2025
Loading…